340B Needs A Stronger Fix Than Dispute Resolution Rule, Provider Lawsuit Against HHS Argues
Drug manufacturer actions against contract pharmacies require immediate attention, provider suit says, though HHS’ 340B dispute resolution process ‘holds promise.’
You may also be interested in...
Ruling halts the 340B rule, and may have relevance in a suit brought by PBMs challenging the ‘rebate rule,’ which was issued in final form after HHS had suspended action on the reg.
Biden Administration’s regulatory freeze suspends HHS action to appoint an administrative dispute resolution board for the 340B program. Good news for manufacturers?
340B Fight: Lilly ‘Disagrees’ With HHS Advisory Stating Discounts To Contract Pharmacies Are Required
Lilly will not change its 340B discount restrictions in light of the advisory, which was released after HHS was sued by hospitals and other groups seeking a regulatory response against pharma actions.